This is the authors' abstract. We don't add key points for this paper.
There are several recognised clinical and radiographic presentations of eosinophilic lung disease. These include simple pulmonary eosinophilia (SPE), chronic eosinophilic pneumonia (CEP), acute eosinophilic pneumonia (AEP), allergic bronchopulmonary aspergillosis (ABPA) and pulmonary eosinophilia associated with a systemic disease. [1] Systemic diseases implicated include eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome (CSS) and the hypereosinophilic syndrome (HES). Eosinophilic pneumonias may be idiopathic or secondary to a known cause. Causes may include drugs, irradiation, toxins and infections. The infections may be fungal, parasitic or mycobacterial in nature. AEP, CEP and ABPA have radiographic features that may be suggestive, if not pathognomonic, in several instances. In addition, varying degrees of pulmonary eosinophilia may be associated with diffuse lung diseases, neoplasia and connective tissue diseases. Finally, a hallmark of eosinophilic lung diseases (with the exception of HES) is their exquisite sensitivity to corticosteroids. The eosinophil leukocyte is of obvious importance. It is a granulocyte named for its abundance of eosinophilic granules in the cytoplasm. Mature eosinophils circulate for approximately 24 hours before being recruited into target tissues where they undergo rapid apoptosis if no survival factors are present. [2]
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kate Dudgeon (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: